PDL BioPharma seeks to provide a significant return for its shareholders by acquiring commercial stage pharmaceutical assets with multiple year revenue growth potential as well as late clinical stage pharmaceutical products.

CURRENT ALTERNATIVE INVESTMENTS

CONCLUDED ALTERNATIVE INVESTMENTS